These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 7664215

  • 1. Efficacy and safety of losartan.
    Goldberg A, Sweet C.
    Can J Cardiol; 1995 Aug; 11 Suppl F():27F-32F. PubMed ID: 7664215
    [Abstract] [Full Text] [Related]

  • 2. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
    Mallion JM, Goldberg AI.
    Blood Press Suppl; 1996 Aug; 2():82-6. PubMed ID: 8913546
    [Abstract] [Full Text] [Related]

  • 3. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS.
    Arch Intern Med; 1996 Feb 12; 156(3):278-85. PubMed ID: 8572837
    [Abstract] [Full Text] [Related]

  • 4. Blood pressure effects of the angiotensin II receptor blocker, losartan.
    Weber MA, Byyny RL, Pratt JH, Faison EP, Snavely DB, Goldberg AI, Nelson EB.
    Arch Intern Med; 1995 Feb 27; 155(4):405-11. PubMed ID: 7848024
    [Abstract] [Full Text] [Related]

  • 5. Losartan potassium as initial therapy in patients with severe hypertension.
    Dunlay MC, Fitzpatrick V, Chrysant S, Francischetti EA, Goldberg AI, Sweet CS.
    J Hum Hypertens; 1995 Nov 27; 9(11):861-7. PubMed ID: 8583463
    [Abstract] [Full Text] [Related]

  • 6. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.
    Chan JC, Critchley JA, Lappe JT, Raskin SJ, Snavely D, Goldberg AI, Sweet CS.
    J Hum Hypertens; 1995 Sep 27; 9(9):765-71. PubMed ID: 8551492
    [Abstract] [Full Text] [Related]

  • 7. The clinical efficacy and tolerability of the angiotensin II-receptor antagonist losartan in Japanese patients with hypertension.
    Ogihara T, Yoshinaga K.
    Blood Press Suppl; 1996 Sep 27; 2():78-81. PubMed ID: 8913545
    [Abstract] [Full Text] [Related]

  • 8. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
    Goldberg AI, Dunlay MC, Sweet CS.
    Am J Cardiol; 1995 Apr 15; 75(12):793-5. PubMed ID: 7717281
    [Abstract] [Full Text] [Related]

  • 9. Controlling blood pressure throughout the day: issues in testing a new anti-hypertensive agent.
    Weber MA, Neutel JM, Smith DH.
    J Hum Hypertens; 1995 Nov 15; 9 Suppl 5():S29-35. PubMed ID: 8583478
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B, Keller SE, Makris L, Goldberg AI, Sweet CS, Lim NY.
    Am J Hypertens; 1995 Jun 15; 8(6):578-83. PubMed ID: 7662242
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive efficacy of the angiotensin II AT1-receptor antagonist losartan: results of a randomized, double-blind, placebo-controlled, parallel-group trial using 24-hour blood pressure monitoring. Ambulatory Blood Pressure Monitoring Study Group.
    Byyny RL.
    Blood Press Suppl; 1996 Jun 15; 2():71-7. PubMed ID: 8913544
    [Abstract] [Full Text] [Related]

  • 12. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y.
    Can J Cardiol; 1995 Aug 15; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
    J Hum Hypertens; 2004 Mar 15; 18(3):215-22. PubMed ID: 14973517
    [Abstract] [Full Text] [Related]

  • 14. An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.
    Byyny RL, Merrill DD, Bradstreet TE, Sweet CS.
    Cardiovasc Drugs Ther; 1996 Jul 15; 10(3):313-9. PubMed ID: 8877074
    [Abstract] [Full Text] [Related]

  • 15. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
    Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Julius S, Kjeldsen S, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H.
    Am J Hypertens; 1997 Jul 15; 10(7 Pt 1):705-13. PubMed ID: 9234823
    [Abstract] [Full Text] [Related]

  • 16. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension.
    Goa KL, Wagstaff AJ.
    Drugs; 1996 May 15; 51(5):820-45. PubMed ID: 8861549
    [Abstract] [Full Text] [Related]

  • 17. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
    Naidoo DP, Sareli P, Marin F, Aroca-Martinez G, Maritz FJ, Jardim PC, Guerrero AA, Thompson CA, Bero T, Drazka J, Kosmalova V, Dumortier T, Smith RD.
    Adv Ther; 1999 May 15; 16(5):187-99. PubMed ID: 10915394
    [Abstract] [Full Text] [Related]

  • 18. ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group.
    Ramsay LE, Yeo WW.
    J Hum Hypertens; 1995 Nov 15; 9 Suppl 5():S51-4. PubMed ID: 8583482
    [Abstract] [Full Text] [Related]

  • 19. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B.
    Curr Med Res Opin; 2001 Nov 15; 17(1):8-17. PubMed ID: 11464450
    [Abstract] [Full Text] [Related]

  • 20. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.
    Nielsen S, Dollerup J, Nielsen B, Jensen HA, Mogensen CE.
    Nephrol Dial Transplant; 1997 Nov 15; 12 Suppl 2():19-23. PubMed ID: 9269694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.